Sign In or Subscribe

Get Full access to Top 1000 data, subscribe from only €29

Register Now »

Biomarin

Add to comparison

BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.

Financial Data

31st Dec 17 Source: CRO
- €491.6 million turnover
- €1 million profit
- 300 employees
- Auditor: KPMG
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
31st Dec 16 Source: CRO
- €377.3 million turnover
- €0.1 million profit
- 236 employees
- Auditor: KPMG
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
2 more years available »

Ranking

By Turnover

(€491.6 million)

159^th in Top Companies
23^rd in Health

By Employees

(300)

477^th in Top Companies
69^th in Health

Nearest in Top 1000

Top 5 By Industry

159^th in Top Companies

By Turnover

Employees: 300
Turnover: €491.6 million

Employees

Michael O’Donnell CEO/Managing Director

Latest News

Newsletter